Page last updated: 2024-10-22

amodiaquine and Ovarian Neoplasms

amodiaquine has been researched along with Ovarian Neoplasms in 1 studies

Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.

Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, MY1
Apellániz-Ruiz, M1
Johansson, I1
Vikingsson, S1
Bergmann, TK1
Brøsen, K1
Green, H1
Rodríguez-Antona, C1
Ingelman-Sundberg, M1

Other Studies

1 other study available for amodiaquine and Ovarian Neoplasms

ArticleYear
Role of cytochrome P450 2C8*3 (CYP2C8*3) in paclitaxel metabolism and paclitaxel-induced neurotoxicity.
    Pharmacogenomics, 2015, Volume: 16, Issue:9

    Topics: Alleles; Amodiaquine; Antineoplastic Agents, Phytogenic; Aryl Hydrocarbon Hydroxylases; Breast Neopl

2015